Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Metadata
Title
Incidental Discovery of Retained Triple Lumen Catheter Guidewire
Publication date
01-03-2017
Published in
Journal of General Internal Medicine / Issue 3/2017
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3798-8

Other articles of this Issue 3/2017

Journal of General Internal Medicine 3/2017 Go to the issue

Editorial

Borrowing from Strength

Original Research

“It’s been an Experience, a Life Learning Experience”: A Qualitative Study of Hospitalized Patients with Substance Use Disorders

Capsule Commentary

Capsule Commentary on Velez et al., “It’s Been an Experience, a Life Learning Experience”: A Qualitative Study of Hospitalized Patients with Substance Use Disorders

Editorial

Isolation Precautions for Hospitalized Patients: The Challenges of Identifying Unintended Individual Consequences and Measuring the Prevention of Community Harm

Original Research

Defining Team Effort Involved in Patient Care from the Primary Care Physician’s Perspective

Innovation and Improvement: Innovations in Medical Education

Development and Implementation of a Novel HIV Primary Care Track for Internal Medicine Residents

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits